Skip to main content
Premium Trial:

Request an Annual Quote

BHB Licenses Life Technologies' PCR Patents

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bar Harbor Biotechnology said today that it has licensed PCR and real-time PCR patents from Life Technologies.

The agreement enables BHB to provide contract research services based on its StellARray and XenoQ systems. Researchers can purchase assays based on those two technologies through BHB's exclusive distributor, Lonza. BHB would then perform the PCR services and analyze the data using the Global Patter Recognition analysis software, which is exclusive to the firm.

"We believe there are many laboratories that do not have the resources to utilize our technology," BHB's VP of Product Development, Dan Shaffer, said in a statement. "We wanted to change that and make it easier for all labs to make use of our systems."

BHB said that it has expanded its staff to incorporate the new services, and CEO Robert Phelps said that the expansion was made possible with support from the State of Maine. "This new expansion was part of a strategic plan to create new high tech jobs here in Maine," he said.

Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more